[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368579-105":59,"doc-detail-368579-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-review-of-bayesian-network-applications-in-gastrointestinal-cancers-review","Comprehensive review of Bayesian network applications in gastrointestinal cancers - Review","","Gastrointestinal cancers, including esophageal, gastric, colorectal, liver, gallbladder, cholangiocarcinoma, and pancreatic cancers, create a major global health burden due to high mortality and poor prognosis, particularly at advanced stages. Their heterogeneity in clinical features and etiologies demands innovative strategies for management. Bayesian networks are highlighted as a framework to handle uncertainty, integrate diverse data, and enable clinical decision-making. The review addresses key problems such as risk-factor identification, early detection, treatment optimization, and prognosis prediction. It also discusses barriers to adoption, including data quality constraints, computational complexity, and limited clinical uptake, and outlines future directions such as advanced BN algorithms, multi-omics integration, and practical clinical implementation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-review-of-bayesian-network-applications-in-gastrointestinal-cancers-review/368579/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-review-of-bayesian-network-applications-in-gastrointestinal-cancers-review/368579.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which gastrointestinal cancers does the review focus on?","Question",{"text":112,"@type":113},"The review covers esophageal, gastric, colorectal, liver, gallbladder, cholangiocarcinoma, and pancreatic cancers, emphasizing their high mortality and poor outcomes, especially at late diagnosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do Bayesian networks support clinical decision-making in gastrointestinal cancers?",{"text":117,"@type":113},"Bayesian networks help manage uncertainty, integrate heterogeneous data sources, and model relationships that support tasks including risk prediction, early detection, and prognosis assessment.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges limit the widespread adoption of Bayesian networks?",{"text":121,"@type":113},"Adoption is hindered by data quality limitations, computational complexity, and the need for greater clinical acceptance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368579,1790785931,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","| W | J | C | O | World Journal of\u003Cbr>Clinical Oncology |\n| --- | --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Clin Oncol 2025 June 24; 16(6): 104299  \nDOI: 10.5306/wjco.v16.i6.104299 ISSN 2218-4333 (online)  \nREVIEW  \nComprehensive review of Bayesian network applications in gastrointestinal cancers  \nMin-Na Zhang, Meng-Ju Xue, Bao-Zhen Zhou, Jing Xu, Hong-Kai Sun, Ji-Han Wang, Yang-Yang Wang  \nSpecialty type: Oncology  \nProvenance and peer review:  \nInvited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade B, Grade B, Grade D  \nNovelty: Grade A, Grade B, Grade D  \nCreativity or Innovation: Grade A, Grade A, Grade D  \nScientific Significance: Grade A, Grade A, Grade D  \nP-Reviewer: Liu HR; Su YH  \nReceived: December 16, 2024  \nRevised: April 11, 2025  \nAccepted: May 21, 2025  \nPublished online: June 24, 2025  \nProcessing time: 185 Days and 19.9 Hours  \nMin-Na Zhang, Meng-Ju Xue, Bao-Zhen Zhou, Jing Xu, Hong-Kai Sun, Ji-Han Wang, School of Medicine, Xi'an International University, Xi'an 710077, Shaanxi Province, China  \nYang-Yang Wang, School of Physics and Electronic Information, Yan’an University, Yan’an 716000, Shaanxi Province, China  \nCo-first authors: Min-Na Zhang and Meng-Ju Xue.  \nCo-corresponding authors: Ji-Han Wang and Yang-Yang Wang.  \nCorresponding author: Ji-Han Wang, PhD, Assistant Professor, School of Medicine, Xi'an International University, No. 18 Yudou Road, Yanta District, Xi'an 710077, Shaanxi Province, [China.](China. 513837742@qq.com)[ 513837742@qq.com](China. 513837742@qq.com)  \nAbstract  \nGastrointestinal cancers, including esophageal, gastric, colorectal, liver, gallbladder, cholangiocarcinoma, and pancreatic cancers, pose a significant global health challenge due to their high mortality rates and poor prognosis, particularly when diagnosed at advanced stages. These malignancies, characterized by diverse clinical presentations and etiologies, require innovative approaches for improved management. Bayesian networks (BN) have emerged as a powerful tool in this field, offering the ability to manage uncertainty, integrate heterogeneous data sources, and support clinical decision-making. This review explores the application of BN in addressing critical challenges in gastrointestinal cancers, includingthe identification of risk factors, early detection, treatment optimization, and prognosis prediction. By integrating genetic predispositions, lifestyle factors, and clinical data, BN hold the potential to enhance survival rates and improve quality of life through personalized treatment strategies. Despite their promise, the widespread adoption of BN is hindered by challenges such as data quality limitations, computational complexities, and the need for greater clinical acceptance. The review concludes with future research directions, emphasizing the development of advanced BN algorithms, the integration of multi-omics data, and strategies to ensure clinical applicability, aiming to fully realize the potential of BN in personalized medicine for gastrointestinal cancers.  \nKey Words: Gastrointestinal cancers; Bayesian networks; Heterogeneous data integration; Early detection; Risk prediction; Prognosis; Personalized medicine  \n WJCO  [https://www.wjgnet.com](https://www.wjgnet.com) 1 June 24, 2025  Volume 16  Issue 6   \nZhang MN et al. BN in GI cancers  \n©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.  \nCore Tip: Bayesian networks (BN) provide a powerful framework for managing the complexity and uncertainty in gastrointestinal cancer research and clinical practice. By integrating diverse data types and modeling causal relationships, BN facilitate personalized treatment strategies. However, challenges such as data availability, computational demands, and clinical adoption must be addressed to fully unlock their potential fo","cbCaiuKS3iVMW3yU","https://ap.wps.com/l/cbCaiuKS3iVMW3yU","pdf",1351430,"English","# Introduction\n# Bayesian networks for risk factors and early detection\n# Bayesian networks for treatment optimization\n# Bayesian networks for prognosis prediction\n# Barriers to adoption and future directions","[{\"question\":\"Which gastrointestinal cancers does the review focus on?\",\"answer\":\"The review covers esophageal, gastric, colorectal, liver, gallbladder, cholangiocarcinoma, and pancreatic cancers, emphasizing their high mortality and poor outcomes, especially at late diagnosis.\"},{\"question\":\"How do Bayesian networks support clinical decision-making in gastrointestinal cancers?\",\"answer\":\"Bayesian networks help manage uncertainty, integrate heterogeneous data sources, and model relationships that support tasks including risk prediction, early detection, and prognosis assessment.\"},{\"question\":\"What challenges limit the widespread adoption of Bayesian networks?\",\"answer\":\"Adoption is hindered by data quality limitations, computational complexity, and the need for greater clinical acceptance.\"}]","Comprehensive review of Bayesian network applications in gastrointestinal cancers - Review | PDF",1790177561,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01eb3b1e2492c13e9effa53a17dfd70b.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/919f2e43ddb6bac053fa6da9cd046848.webp",982,1389,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef38bb6f2e9a018e270a7ca9cd7e1b69.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e2b100f13d806310bf94830c9474cb0.webp",980,1386]